Shortage

The HMOs received a British alternative to the drug "Slow-Derlin" in an 80 mg dosage, after Maariv exposed months of shortage. The drug is intended, among other things, for migraines, blood pressure, and tremors; availability should be checked and treatment should not be changed without consultation.

A logistical failure at Tnuva has caused a chronic shortage of cottage cheese in major retail chains. While the company promises to restore supply levels, private sellers have begun listing the product online at inflated prices.